HOME >> MEDICINE >> NEWS
USC/Norris Study Finds No Benefit Of Finasteride In Preventing Prostate Cancer In Men At Elevated Risk


Study Suggests That Drug Could Leave Certain Men At Higher Risk

LOS ANGELES, Calif., Aug. 1, 1998 -- A new study by USC/Norris Cancer Center scientists raises serious questions about the potential use of the drug finasteride to prevent prostate cancer.

Scientists have theorized that finasteride, sold under the brand name Proscar and commonly used to treat benign prostate disease, might offer men a way to cut their risk of developing prostate cancer.

Yet, "it appears that finasteride may not be effective as a chemopreventive agent against prostate cancer, at least in men with high PSA levels," says Ronald K. Ross, M.D., USC professor of preventive medicine and deputy director of the USC/Norris Cancer Center.

"There may even be a subgroup of patients in whom the drug actually could be harmful," says co-author Richard J. Cote, M.D., USC associate professor of pathology and urology. Ross and Cote, along with Eila C. Skinner, M.D., USC associate professor of urology, led the study, which appears in the first August issue of the British Journal of Cancer.

Prostate cancer is the most frequently diagnosed cancer in the United States, and proves fatal for some 40,000 men each year. At present, there's no proven way to prevent the disease.

USC/Norris researchers have long led research on the role of the male hormones androgens in spurring prostate cancer growth. Ross and his colleagues first proposed that lowering levels of the androgen most active in the prostate, called dihydrotestosterone (DHT), could possibly prevent prostate cancer. Ross' team was also the first to suggest that finasteride, which lowers the levels of DHT by blocking the enzyme that converts testosterone into DHT, might prevent the formation of prostate cancer.

The National Cancer Institute (NCI) is in the midst of a large national clinical trial to determine if finasteride can reduce the incidence of prostate cancer. The seven-year NCI study has
'"/>

Contact: Eva Emerson or Brenda Maceo
eemerson@hsc.usc.edu
323-442-2830
University of Southern California
1-Aug-1998


Page: 1 2 3 4

Related medicine news :

1. USC/Norris oncologists test new front-line therapy for pancreatic cancer
2. Study of energy and health in Africa focuses spotlight on charcoal and forest management
3. Study shows promise in identifying kidney failure
4. Study shows patch therapy may be as effective as oral medications
5. Study shows soy is well accepted in school lunches
6. Study finds that coordinating care of chronically ill patients does not increase liability
7. Study provides new estimates of the causes of child mortality worldwide
8. Study finds factors linked to substance use disorder relapse among health care professionals
9. Study finds majority of women willing to accept cervical cancer vaccine for self and children
10. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
11. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... (PRWEB) , ... September 03, 2020 , ... ... Spa Show 2021 will be held Wednesday, April 7, to Saturday, April 10, ... January. , Medical Spa Show is a national trade show for non-invasive medical ...
(Date:9/2/2020)... ... 02, 2020 , ... RAM Technologies, Inc., the perennial leader ... Special Needs plans, is proud to support the 2020 National Conferences on Medicare, ... supporting the event as a sponsor and exhibitor and will be showcasing their ...
(Date:9/1/2020)... ... September 01, 2020 , ... Feeding Matters , the first organization in ... Disorder (PFD), is pleased to announce that the U.S. Centers for Disease Control and ... in the next edition of the U.S. International Classification of Diseases (ICD ) ...
(Date:8/31/2020)... ... August 31, 2020 , ... Cardiothoracic surgeons at Allegheny General ... Carnegie Mellon University (CMU) to develop a new heart monitoring device designed to ... surgery. , The AGH/CMU team was recently awarded a “Trailblazer” grant from the ...
(Date:8/31/2020)... Miss. (PRWEB) , ... August 31, 2020 , ... ... (GCPP) recently donated 1,400 N95 face masks to medical first responders across the ... continued to make donations of personal protective equipment (PPE) medical centers , ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... ... 01, 2020 , ... September is National Ovarian Cancer Awareness Month. Ovarian ... other cancer of the female reproductive system. The American Cancer Society estimates that ... women will die from this disease. Throughout the month of September, Women’s Excellence ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... research and advisory guide, has named Cloudticity a Gold winner in the 15th ... industry and peer recogniti o ns from Network Products Guide honoring ...
(Date:8/27/2020)... Pa. (PRWEB) , ... August 27, 2020 , ... ... care coordination software, today announced the successful completion of their 2020 System and ... well as their HITRUST® interim assessment and MARS-E compliance assessment. These achievements reflect ...
Breaking Medicine Technology:
Cached News: